“According to the research report, the global migraine drugs market was valued at USD 4.34 billion in 2021 and is expected to reach USD 8.79 billion by 2030, to grow at a CAGR of 8.5% during the forecast period.” Polaris Market Research announces the release of its latest report on Migraine Drugs Market Analysis and Forecast: Industry Trends, Growth Drivers, Challenges, and...